** Shares of Melodiol Global Health ME1.AX soar as much as
25% to A$0.01
** Co says new sales during Q3 takes CY2023 revenue to date
to A$8.6 mln ($5.84 mln), compared to revenue of A$8.7 mln for
the entirety of CY22
** Posts revenue of A$4.74 mln for the second quarter, a
105% increase QoQ
** Over 8 mln shares traded as of 0402 GMT, vs 30-day avg of
14.1 mln
** Stock has fallen 60% this year, as of last close
($1 = 1.4736 Australian dollars)
(Reporting by Jaskiran Singh in Bengaluru)
((Jaskiran.Singh@thomsonreuters.com;))